Keunhee Oh

Summary

Affiliation: Seoul National University
Country: Korea

Publications

  1. ncbi Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation
    Keunhee Oh
    Laboratory of Immunology, Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea
    Eur J Immunol 41:392-402. 2011
  2. ncbi CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway
    Hyung Bae Park
    Department of Anatomy, Seoul National University College of Medicine, Seoul, South Korea
    Transplantation 90:825-35. 2010
  3. ncbi Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation
    Keunhee Oh
    Laboratory of Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea Transplantation Research Institute, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea Cancer Research Institute, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea
    Clin Immunol 145:122-32. 2012
  4. ncbi Donor-strain-derived immature dendritic cell pre-treatment induced hyporesponsiveness against allogeneic antigens
    Hee Gyung Kang
    Kidney Research Institute, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
    Immunology 129:567-77. 2010
  5. ncbi Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
    Keunhee Oh
    Laboratory of Immunology, Department of Biomedical Sciences Transplantation Research Institute, Seoul National University College of Medicine, Seoul 110 799, Korea
    J Exp Med 208:1707-19. 2011
  6. ncbi Both CD45RA+ and CD45RO+ human CD4+ T cells drive direct xenogeneic T-cell responses against porcine aortic endothelial cells
    Chi Hwa Kim
    Laboratory of Immunology, Department of Anatomy, College of Medicine, Seoul National University, Seoul, Korea
    Xenotransplantation 17:224-32. 2010
  7. ncbi Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response
    Keunhee Oh
    Department of Biomedical Sciences, Laboratory of Immunology and Cancer Biology, Seoul, Korea
    Respir Res 14:35. 2013
  8. ncbi Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo
    So Mi Oh
    Laboratory of Immunology, Transplantation Research Institute, Seoul, Korea
    J Korean Med Sci 26:1270-6. 2011
  9. ncbi Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells
    Keunhee Oh
    Laboratory of Immunology, Interdisciplinary Program of Tumor Biology, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon dong Chongno gu, Seoul 110 799, Korea
    Breast Cancer Res 13:R96. 2011
  10. ncbi Maturation-resistant dendritic cells ameliorate experimental autoimmune uveoretinitis
    Keunhee Oh
    Laboratory of Immunology, Transplantation Research Institute, Seoul National University College of Medicine, Seoul 110 799, Korea
    Immune Netw 11:399-405. 2011

Collaborators

  • Yon Su Kim
  • Dong Young Noh
  • Wenda Gao
  • Hua Gu
  • Terry B Strom
  • Dong Sup Lee
  • Hyung Bae Park
  • So Mi Oh
  • Chi Hwa Kim
  • Hee Gyung Kang
  • Gene Lee
  • Jaejin Cho
  • Dae Hyun Jeon
  • Jung Eun Lee
  • Dong Eun Kim
  • Se Han Lee
  • Nandin Garmaa
  • Seung Hee Yang
  • Myung Won Seo
  • Seul Bee Lee
  • Ji Hye Yang
  • Ok Jin Byoun
  • Hee Yoon Lee
  • Dong-Sup Lee
  • Jeong R Lee
  • Dae-Hyun Jeon
  • Hyung-Bae Park
  • Dong H Nam
  • Byoung C Oh
  • Chi H Kim

Detail Information

Publications13

  1. ncbi Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation
    Keunhee Oh
    Laboratory of Immunology, Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea
    Eur J Immunol 41:392-402. 2011
    ..Our results indicate that invariant NKT cells inhibited autoimmune uveitis predominantly through the cytokine-independent inhibition of Th17 differentiation...
  2. ncbi CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway
    Hyung Bae Park
    Department of Anatomy, Seoul National University College of Medicine, Seoul, South Korea
    Transplantation 90:825-35. 2010
    ..Here, we evaluated the protective effect of CP-690550, a newly developed Janus kinase inhibitor, in an acute GVHD model...
  3. ncbi Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation
    Keunhee Oh
    Laboratory of Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea Transplantation Research Institute, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea Cancer Research Institute, Seoul National University College of Medicine, 103 Daehak ro Jongno gu, Seoul, Republic of Korea
    Clin Immunol 145:122-32. 2012
    ..This study is the first to report a pathogenic role for TG2 in the EAE progress and suggests that therapeutic targeting of TG2 may be effective against multiple sclerosis...
  4. ncbi Donor-strain-derived immature dendritic cell pre-treatment induced hyporesponsiveness against allogeneic antigens
    Hee Gyung Kang
    Kidney Research Institute, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
    Immunology 129:567-77. 2010
    ..Consequently, FIDC-induced T-cell hyporesponsiveness could reflect anergy rather than specific deletion. Our findings suggest that FIDCs of donor strain could be used to induce long-term graft survival...
  5. ncbi Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
    Keunhee Oh
    Laboratory of Immunology, Department of Biomedical Sciences Transplantation Research Institute, Seoul National University College of Medicine, Seoul 110 799, Korea
    J Exp Med 208:1707-19. 2011
    ..Therefore, TG2 represents an interesting potential target for therapeutic intervention...
  6. ncbi Both CD45RA+ and CD45RO+ human CD4+ T cells drive direct xenogeneic T-cell responses against porcine aortic endothelial cells
    Chi Hwa Kim
    Laboratory of Immunology, Department of Anatomy, College of Medicine, Seoul National University, Seoul, Korea
    Xenotransplantation 17:224-32. 2010
    ..Here, we sought to determine whether human peripheral blood memory/activated phenotype T cells are directly responsive to porcine endothelial cells...
  7. ncbi Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response
    Keunhee Oh
    Department of Biomedical Sciences, Laboratory of Immunology and Cancer Biology, Seoul, Korea
    Respir Res 14:35. 2013
    ..In this study, we evaluated the role of TG2 in the pathogenesis of allergic asthma, particularly whether TG2 affects initial activation signaling leading to Th2 differentiation against antigens...
  8. ncbi Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo
    So Mi Oh
    Laboratory of Immunology, Transplantation Research Institute, Seoul, Korea
    J Korean Med Sci 26:1270-6. 2011
    ..These results suggest that the combined use of chemokines and adjuvant molecules may be a possible strategy in clinical tumor immunotherapy...
  9. ncbi Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells
    Keunhee Oh
    Laboratory of Immunology, Interdisciplinary Program of Tumor Biology, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon dong Chongno gu, Seoul 110 799, Korea
    Breast Cancer Res 13:R96. 2011
    ....
  10. ncbi Maturation-resistant dendritic cells ameliorate experimental autoimmune uveoretinitis
    Keunhee Oh
    Laboratory of Immunology, Transplantation Research Institute, Seoul National University College of Medicine, Seoul 110 799, Korea
    Immune Netw 11:399-405. 2011
    ..Recently our group reported that donor strain-derived immature DC pretreatment successfully controlled the adverse immune response during allogeneic transplantation...
  11. ncbi Porcine PD-L1: cloning, characterization, and implications during xenotransplantation
    Dae Hyun Jeon
    Laboratory of Molecular Genetics and Stem Cell Differentiation, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea
    Xenotransplantation 14:236-42. 2007
    ..Endogenous negative regulatory signals like the programmed death 1 (PD-1)-programmed death ligand 1 (PD-L1) system are candidate targets for the control of cell-mediated xenogeneic immune response...
  12. ncbi Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity
    Keunhee Oh
    Laboratory of Immunology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
    J Immunol 174:2030-6. 2005
    ..Taken together, we concluded that CD1d-dependent NKT cells may directly affect the outcome of allogeneic skin graft through an IL-10-dependent regulatory mechanism...
  13. ncbi A receptor-independent, cell-based JAK activation assay for screening for JAK3-specific inhibitors
    Keunhee Oh
    Laboratory of Immunology, Department of Anatomy, Seoul National University College of Medicine, Republic of Korea
    J Immunol Methods 354:45-52. 2010
    ..Thus, we generated a receptor-independent, cell-based selective screening system for specific JAK3 inhibitors, which is easily convertible to a high-throughput screening platform...